Patents by Inventor Alan W. Heldman

Alan W. Heldman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210145893
    Abstract: Compositions comprising stem cells delivered into infarcted myocardium by endocardial injection, engraft and differentiate into myocytes, endothelial cells, and vascular smooth muscle, and do so without the requirement for survival enhancing modification. These cells engraft whether injected acutely (days) or late (months) after myocardial infarction, and the efficiency of engraftment correlates with the functional recovery of the heart. The stem cells also recruit endogenous cardiac precursor cells, reconstitute myocardial stem cell niches, and enhance endogenous cell differentiation into myocytes.
    Type: Application
    Filed: June 26, 2020
    Publication date: May 20, 2021
    Inventors: Joshua HARE, Konstantinos CHATZISTERGOS, Alan W. HELDMAN
  • Patent number: 10874698
    Abstract: Compositions comprising stem cells delivered into infarcted myocardium by endocardial injection, engraft and differentiate into myocytes, endothelial cells, and vascular smooth muscle, and do so without the requirement for survival enhancing modification. These cells engraft whether injected acutely (days) or late (months) after myocardial infarction, and the efficiency of engraftment correlates with the functional recovery of the heart. The stem cells also recruit endogenous cardiac precursor cells, reconstitute myocardial stem cell niches, and enhance endogenous cell differentiation into myocytes.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: December 29, 2020
    Assignee: VESTION, INC.
    Inventors: Joshua Hare, Konstantinos Chatzistergos, Alan W. Heldman
  • Patent number: 10709742
    Abstract: Compositions comprising stem cells delivered into infarcted myocardium by endocardial injection engraft and differentiate into myocytes, endothelial cells, and vascular smooth muscle, and do so without the requirement for survival enhancing modification. These cells engraft whether injected acutely (days) or late (months) after myocardial infarction, and the efficiency of engraftment correlates with the functional recovery of the heart. The stem cells also recruit endogenous cardiac precursor cells, reconstitute myocardial stem cell niches, and enhance endogenous cell differentiation into myocytes.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: July 14, 2020
    Assignee: VESTION, INC.
    Inventors: Joshua Hare, Konstantinos Chatzistergos, Alan W. Heldman
  • Patent number: 10265165
    Abstract: Disclosed is a prosthetic heart valve incorporating one or more linking elements adapted for anchoring, aligning, stabilizing, fixing, or otherwise enabling the implantation of other prosthetic devices, including other prosthetic heart valves, in or around the heart.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: April 23, 2019
    Inventor: Alan W. Heldman
  • Publication number: 20190076481
    Abstract: Compositions comprising stem cells delivered into infarcted myocardium by endocardial injection engraft and differentiate into myocytes, endothelial cells, and vascular smooth muscle, and do so without the requirement for survival enhancing modification. These cells engraft whether injected acutely (days) or late (months) after myocardial infarction, and the efficiency of engraftment correlates with the functional recovery of the heart. The stem cells also recruit endogenous cardiac precursor cells, reconstitute myocardial stem cell niches, and enhance endogenous cell differentiation into myocytes.
    Type: Application
    Filed: May 7, 2018
    Publication date: March 14, 2019
    Inventors: Joshua HARE, Konstantinos CHATZISTERGOS, Alan W. HELDMAN
  • Publication number: 20190076480
    Abstract: Compositions comprising stem cells delivered into infarcted myocardium by endocardial injection, engraft and differentiate into myocytes, endothelial cells, and vascular smooth muscle, and do so without the requirement for survival enhancing modification. These cells engraft whether injected acutely (days) or late (months) after myocardial infarction, and the efficiency of engraftment correlates with the functional recovery of the heart. The stem cells also recruit endogenous cardiac precursor cells, reconstitute myocardial stem cell niches, and enhance endogenous cell differentiation into myocytes.
    Type: Application
    Filed: May 7, 2018
    Publication date: March 14, 2019
    Inventors: Joshua Hare, Konstantinos Chatzistergos, Alan W. Heldman
  • Patent number: 9980985
    Abstract: Compositions comprising stem cells delivered into infarcted myocardium by endocardial injection, engraft and differentiate into myocytes, endothelial cells, and vascular smooth muscle, and do so without the requirement for survival enhancing modification. These cells engraft whether injected acutely (days) or late (months) after myocardial infarction, and the efficiency of engraftment correlates with the functional recovery of the heart. The stem cells also recruit endogenous cardiac precursor cells, reconstitute myocardial stem cell niches, and enhance endogenous cell differentiation into myocytes.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: May 29, 2018
    Assignee: Vestion, Inc.
    Inventors: Joshua Hare, Konstantinos Chatzistergos, Alan W. Heldman
  • Publication number: 20160354202
    Abstract: Disclosed is a prosthetic heart valve incorporating one or more linking elements adapted for anchoring, aligning, stabilizing, fixing, or otherwise enabling the implantation of other prosthetic devices, including other prosthetic heart valves, in or around the heart.
    Type: Application
    Filed: August 5, 2016
    Publication date: December 8, 2016
    Inventor: Alan W. Heldman
  • Patent number: 9445894
    Abstract: Disclosed is a prosthetic heart valve incorporating one or more linking elements adapted for anchoring, aligning, stabilizing, fixing, or otherwise enabling the implantation of other prosthetic devices, including other prosthetic heart valves, in or around the heart.
    Type: Grant
    Filed: June 17, 2014
    Date of Patent: September 20, 2016
    Inventor: Alan W. Heldman
  • Publication number: 20150073542
    Abstract: Disclosed is a prosthetic heart valve incorporating one or more linking elements adapted for anchoring, aligning, stabilizing, fixing, or otherwise enabling the implantation of other prosthetic devices, including other prosthetic heart valves, in or around the heart.
    Type: Application
    Filed: June 17, 2014
    Publication date: March 12, 2015
    Inventor: Alan W. Heldman
  • Publication number: 20140369976
    Abstract: Compositions comprising stem cells delivered into infarcted myocardium by endocardial injection, engraft and differentiate into myocytes, endothelial cells, and vascular smooth muscle, and do so without the requirement for survival enhancing modification. These cells engraft whether injected acutely (days) or late (months) after myocardial infarction, and the efficiency of engraftment correlates with the functional recovery of the heart. The stem cells also recruit endogenous cardiac precursor cells, reconstitute myocardial stem cell niches, and enhance endogenous cell differentiation into myocytes.
    Type: Application
    Filed: August 29, 2014
    Publication date: December 18, 2014
    Inventors: Joshua HARE, Konstantinos CHATZISTERGOS, Alan W. HELDMAN
  • Publication number: 20030215564
    Abstract: Methods and apparatus are disclosed for coating endoprostheses. The methods use distributive forces such as centrifugal force or vibration to distribute a bioactive liquid over the surface of the endoprosthesis. In some embodiments, the endoprosthesis is elongated along the longitudinal axis, and is substantially tubular, such as a stent. In other embodiments, the force is applied by rotating the endoprosthesis at speeds between 100-100,000 RPM, or by vibrating it at frequencies between about 10 Hz and about 200,000 Hz. The invention also includes a device for providing a predictable coating on the surface of an endoprosthesis, which includes means for applying bioactive liquid to the endoprosthesis, and means for applying centrifugal force or vibration to distribute the bioactive liquid. The invention also includes endoprostheses that have been subjected to centrifugal force to distribute a bioactive liquid coating layer.
    Type: Application
    Filed: December 19, 2002
    Publication date: November 20, 2003
    Inventors: Phillip F. Heller, Alan W. Heldman, Jeffrey P. Foehlich, Dong-Woon Kim